{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:02:32Z","timestamp":1789916552352,"version":"4.0.1"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004386","name":"University of Malaya","doi-asserted-by":"publisher","award":["UMREG 060\\u20132024"],"award-info":[{"award-number":["UMREG 060\\u20132024"]}],"id":[{"id":"10.13039\/501100004386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004386","name":"University of Malaya","doi-asserted-by":"publisher","award":["UMG019C-2025"],"award-info":[{"award-number":["UMG019C-2025"]}],"id":[{"id":"10.13039\/501100004386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.seizure.2026.07.001","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T22:22:07Z","timestamp":1783203727000},"page":"86-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Time-dependent changes in cerebrospinal fluid cytokines in NORSE and FIRES: A systematic review"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9493-6967","authenticated-orcid":false,"given":"Zhi-Ying","family":"Phong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kheng-Seang","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1082-1956","authenticated-orcid":false,"given":"Won Fen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhailah","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Gee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6756-0411","authenticated-orcid":false,"given":"Ching-Soong","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1217-6380","authenticated-orcid":false,"given":"Si-Lei","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.seizure.2026.07.001_bib0001","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0196-0644(05)80120-9","article-title":"Refractory status epilepticus in adults","volume":"22","author":"Jagoda","year":"1993","journal-title":"Ann Emerg Med"},{"issue":"4","key":"10.1016\/j.seizure.2026.07.001_bib0002","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"Hirsch","year":"2018","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2026.07.001_bib0003","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/epi.14022","article-title":"New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): state of the art and perspectives","volume":"59","author":"Gaspard","year":"2018","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.seizure.2026.07.001_bib0004","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/epi.17950","article-title":"Clinical outcomes among initial survivors of cryptogenic new-onset refractory status epilepsy (NORSE)","volume":"65","author":"Costello","year":"2024","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2026.07.001_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.braindev.2025.104406","article-title":"Immune dysregulation in new-onset refractory status epilepticus (NORSE): current insights and therapeutic perspectives","volume":"47","author":"Hanin","year":"2025","journal-title":"Brain Dev"},{"issue":"8","key":"10.1016\/j.seizure.2026.07.001_bib0006","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2026.07.001_bib0007","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ana.26627","article-title":"Cytokines in new-onset refractory status epilepticus predict outcomes","volume":"94","author":"Hanin","year":"2023","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2026.07.001_bib0008","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2016.09.014","article-title":"Role of the JAK\/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases","volume":"189","author":"Yan","year":"2018","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.seizure.2026.07.001_bib0009","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1111\/epi.17988","article-title":"Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: an interim analysis","volume":"65","author":"Jimenez","year":"2024","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2026.07.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200403","article-title":"Identification of distinct biological groups of patients with cryptogenic NORSE via inflammatory profiling","volume":"12","author":"Guillemaud","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"10.1016\/j.seizure.2026.07.001_bib0011","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1111\/epi.17391","article-title":"International consensus recommendations for management of new onset refractory status epilepticus (NORSE) including febrile infection-related epilepsy syndrome (FIRES): summary and clinical tools","volume":"63","author":"Wickstrom","year":"2022","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2026.07.001_bib0012","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/epi.17933","article-title":"Second-line immunotherapy in new onset refractory status epilepticus","volume":"65","author":"Hanin","year":"2024","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.seizure.2026.07.001_bib0013","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/epi.13750","article-title":"Plasma cytokines associated with febrile status epilepticus in children: a potential biomarker for acute hippocampal injury","volume":"58","author":"Gallentine","year":"2017","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.seizure.2026.07.001_bib0014","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"74","author":"Page","year":"2021","journal-title":"Rev Esp Cardiol"},{"issue":"1","key":"10.1016\/j.seizure.2026.07.001_bib0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"5","key":"10.1016\/j.seizure.2026.07.001_bib0017","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/epi.17523","article-title":"The etiology and mortality of new-onset refractory status epilepticus (NORSE) in adults: a systematic review and meta-analysis","volume":"64","author":"Tharmaraja","year":"2023","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2026.07.001_bib0018","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-2006-923949","article-title":"Biphasic clinical course and early white matter abnormalities may be indicators of neurological sequelae after status epilepticus in children","volume":"37","author":"Okamoto","year":"2006","journal-title":"Neuropediatrics"},{"issue":"7","key":"10.1016\/j.seizure.2026.07.001_bib0019","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jnnp-2014-309388","article-title":"Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus","volume":"86","author":"Sakuma","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.seizure.2026.07.001_bib0020","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/ana.24806","article-title":"Febrile infection-related epilepsy syndrome treated with anakinra","volume":"80","author":"Kenney-Jung","year":"2016","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.seizure.2026.07.001_bib0021","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","article-title":"Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study","volume":"13","author":"Lee","year":"2016","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.seizure.2026.07.001_bib0022","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.25374","article-title":"Tocilizumab treatment for new onset refractory status epilepticus","volume":"84","author":"Jun","year":"2018","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.seizure.2026.07.001_bib0023","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/epi.16275","article-title":"Etiology is the key determinant of neuroinflammation in epilepsy: elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus","volume":"60","author":"Kothur","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.07.001_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577142","article-title":"Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: experience in two patients","volume":"340","author":"Cantar\u00edn-Extremera","year":"2020","journal-title":"J Neuroimmunol"},{"issue":"12","key":"10.1016\/j.seizure.2026.07.001_bib0025","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/acn3.51229","article-title":"Anakinra usage in febrile infection related epilepsy syndrome: an international cohort","volume":"7","author":"Lai","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.seizure.2026.07.001_bib0026","doi-asserted-by":"crossref","DOI":"10.1177\/2329048X20979253","article-title":"Interleukin-6 blockade with tocilizumab in anakinra-refractory febrile infection-related epilepsy syndrome (FIRES)","volume":"7","author":"Stredny","year":"2020","journal-title":"Child Neurol Open"},{"issue":"3","key":"10.1016\/j.seizure.2026.07.001_bib0027","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1684\/epd.2021.1283","article-title":"Super-refractory status epilepticus in autoimmune encephalitis treated with interleukin-1 receptor antagonist, anakinra","volume":"23","author":"Choi","year":"2021","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2026.07.001_bib0028","article-title":"Resolution of cryptogenic new onset refractory status epilepticus with tocilizumab","volume":"15","author":"Donnelly","year":"2021","journal-title":"Epilepsy Behav Rep"},{"issue":"3","key":"10.1016\/j.seizure.2026.07.001_bib0029","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/acn3.51308","article-title":"Intrathecal dexamethasone therapy for febrile infection-related epilepsy syndrome","volume":"8","author":"Horino","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"10.1016\/j.seizure.2026.07.001_bib0030","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1111\/epi.16848","article-title":"Tofacitinib treatment for refractory autoimmune encephalitis","volume":"62","author":"Jang","year":"2021","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2026.07.001_bib0031","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/epi4.12545","article-title":"Sevoflurane as bridge therapy for plasma exchange and Anakinra in febrile infection-related epilepsy syndrome","volume":"6","author":"L'Erario","year":"2021","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2026.07.001_bib0032","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.seizure.2022.06.012","article-title":"Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): effectiveness and safety from a case-series","volume":"100","author":"Aledo-Serrano","year":"2022","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.seizure.2026.07.001_bib0033","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12883-022-02782-3","article-title":"Encephalitis with status epilepticus and stroke as complications of non-severe COVID-19 in a young female patient: a case report","volume":"22","author":"Koh","year":"2022","journal-title":"BMC Neurol"},{"issue":"6","key":"10.1016\/j.seizure.2026.07.001_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5952","article-title":"Anti-inflammatory and immune-mediated therapy for a case of febrile infection-related epilepsy syndrome with rapid recurrence","volume":"10","author":"Kurimoto","year":"2022","journal-title":"Clin Case Rep"},{"issue":"2","key":"10.1016\/j.seizure.2026.07.001_bib0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14581\/jer.22015","article-title":"The increased interleukin-6 levels can be an early diagnostic marker for new-onset refractory status epilepticus","volume":"12","author":"Kwack","year":"2022","journal-title":"J Epilepsy Res"},{"key":"10.1016\/j.seizure.2026.07.001_bib0036","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.seizure.2021.11.014","article-title":"Response to anakinra in new-onset refractory status epilepticus: a clinical case","volume":"94","author":"Palacios-Mendoza","year":"2022","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.seizure.2026.07.001_bib0037","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1550059420975612","article-title":"Use of unconventional therapies in super-refractory status epilepticus: a case report and literature review","volume":"53","author":"Vallecoccia","year":"2022","journal-title":"Clin EEG Neurosci"},{"key":"10.1016\/j.seizure.2026.07.001_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577789","article-title":"Cryptogenic new-onset refractory status epilepticus responded to anti-interleukin-6 treatment","volume":"363","author":"Wadayama","year":"2022","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.seizure.2026.07.001_bib0039","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/epi4.12740","article-title":"Cannabidiol in the acute phase of febrile infection-related epilepsy syndrome (FIRES)","volume":"8","author":"Fetta","year":"2023","journal-title":"Epilepsia Open"},{"issue":"6","key":"10.1016\/j.seizure.2026.07.001_bib0040","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1111\/epi.17591","article-title":"Treatment of new onset refractory status epilepticus\/febrile infection-related epilepsy syndrome with tocilizumab in a child and a young adult","volume":"64","author":"Girardin","year":"2023","journal-title":"Epilepsia"},{"issue":"24","key":"10.1016\/j.seizure.2026.07.001_bib0041","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1212\/WNL.0000000000207068","article-title":"Bridging the gap: tailoring an approach to treatment in febrile infection-related epilepsy syndrome","volume":"100","author":"Goh","year":"2023","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.seizure.2026.07.001_bib0042","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/acn3.51714","article-title":"Systemic inflammatory markers and EEG features of children with FIRES receiving anakinra","volume":"10","author":"Lai","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"10.1016\/j.seizure.2026.07.001_bib0043","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200153","article-title":"Intrathecal dexamethasone in febrile infection-related epilepsy syndrome: a case report","volume":"13","author":"Mehta","year":"2023","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.seizure.2026.07.001_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1100551","article-title":"Long-term neuropsychological outcomes in children with febrile infection-related epilepsy syndrome (FIRES) treated with anakinra","volume":"14","author":"Shrestha","year":"2023","journal-title":"Front Neurol"},{"issue":"11","key":"10.1016\/j.seizure.2026.07.001_bib0045","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/08830738241273448","article-title":"Successful management of febrile infection-related epilepsy syndrome using cytokine-directed therapy","volume":"39","author":"Harrar","year":"2024","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2026.07.001_bib0046","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/jnnp-2024-334285","article-title":"Prognosis prediction and immunotherapy optimisation for cryptogenic new-onset refractory status epilepticus","volume":"96","author":"Jang","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"24","key":"10.1016\/j.seizure.2026.07.001_bib0047","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.2169\/internalmedicine.3392-23","article-title":"Treatment of cryptogenic new-onset refractory status epilepticus (C-NORSE) with tocilizumab","volume":"63","author":"Nakamura","year":"2024","journal-title":"Intern Med"},{"issue":"9","key":"10.1016\/j.seizure.2026.07.001_bib0048","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s13312-024-3284-z","article-title":"A case of FIRES with favorable response to tocilizumab","volume":"61","author":"Vrushabhendra","year":"2024","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.seizure.2026.07.001_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578430","article-title":"IT-DEX and B cell depletion in a child with anti-GAD 65 autoimmune encephalitis presenting as NORSE: a case report","volume":"395","author":"Yarimi","year":"2024","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.seizure.2026.07.001_bib0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/epd2.70011","article-title":"Phenotype, outcome, interleukins, and miRNA levels assessment of new-onset refractory status epilepticus: a prospective cohort study","volume":"27","author":"Adiga","year":"2025","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2026.07.001_bib0051","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12028-025-02254-9","article-title":"Intrathecal dexamethasone as a FIRES extinguisher: a 12-patient clinical experience with usage of intrathecal dexamethasone for febrile infection-related epilepsy syndrome","volume":"43","author":"Farias-Moeller","year":"2025","journal-title":"Neurocrit Care"},{"issue":"4","key":"10.1016\/j.seizure.2026.07.001_bib0052","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/acn3.70011","article-title":"Combined systemic immunotherapy and intrathecal dexamethasone in febrile infection related epilepsy syndrome","volume":"12","author":"Fisher","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.seizure.2026.07.001_bib0053","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/children12040485","article-title":"A case series and review of febrile-infection related epilepsy syndrome (FIRES)","volume":"12","author":"Tahnee Spoden","year":"2025","journal-title":"Children"},{"issue":"2","key":"10.1016\/j.seizure.2026.07.001_bib0054","article-title":"Early intrathecal dexamethasone (IT-Dexa) associated with faster recovery and good outcome in an adolescent with febrile infection-related epilepsy syndrome (FIRES)","volume":"18","author":"Sudarsanan","year":"2025","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.seizure.2026.07.001_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113872","article-title":"Favorable outcomes and FDG-PET changes following tocilizumab treatment for febrile infection-related epilepsy syndrome in a child","volume":"146","author":"Wan","year":"2025","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10.1016\/j.seizure.2026.07.001_bib0056","first-page":"541","article-title":"Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research","volume":"13","author":"Zhou","year":"2010","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"10.1016\/j.seizure.2026.07.001_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu16010001","article-title":"Effects of malnutrition on the immune system and infection and the role of nutritional strategies regarding improvements in children's health status: a literature review","volume":"16","author":"Morales","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.seizure.2026.07.001_bib0058","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1426051","article-title":"NORSE\/FIRES: how can we advance our understanding of this devastating condition?","volume":"15","author":"Champsas","year":"2024","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2026.07.001_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106724","article-title":"Is the antiseizure effect of ketogenic diet in children with drug-resistant epilepsy mediated through proinflammatory cytokines?","volume":"176","author":"Thambi","year":"2021","journal-title":"Epilepsy Res"},{"issue":"11","key":"10.1016\/j.seizure.2026.07.001_bib0060","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.3390\/ijms21113861","article-title":"Sex differences in proatherogenic cytokine levels","volume":"21","author":"Bernardi","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.seizure.2026.07.001_bib0061","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/path.2104","article-title":"Immunosenescence of ageing","volume":"211","author":"Gruver","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.seizure.2026.07.001_bib0062","first-page":"1","article-title":"Cytokines as biomarkers and their respective clinical cutoff levels","volume":"2017","author":"Monastero","year":"2017","journal-title":"Int J Inflam"},{"key":"10.1016\/j.seizure.2026.07.001_bib0063","series-title":"ARUP\u2019s cytokine panel 13, serum","year":"2025"},{"key":"10.1016\/j.seizure.2026.07.001_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2024.113681","article-title":"Specimen type validation and establishment of normal cytokine reference intervals in cerebrospinal fluid","volume":"529","author":"Martins","year":"2024","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.seizure.2026.07.001_bib0065","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fimmu.2019.00480","article-title":"CSF cytokines in aging, multiple sclerosis, and dementia","volume":"10","author":"Hu","year":"2019","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.seizure.2026.07.001_bib0066","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161656","article-title":"Utility of CSF cytokine\/chemokines as markers of active intrathecal inflammation: comparison of demyelinating, anti-NMDAR and enteroviral encephalitis","volume":"11","author":"Kothur","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.seizure.2026.07.001_bib0067","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cyto.2015.10.001","article-title":"CSF cytokines\/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic review","volume":"77","author":"Kothur","year":"2016","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.seizure.2026.07.001_bib0068","doi-asserted-by":"crossref","DOI":"10.1186\/s42494-024-00163-6","article-title":"Cytokines in new-onset refractory status epilepticus: ready for clinical use?","volume":"6","author":"Jin","year":"2024","journal-title":"Acta Epileptologica"},{"key":"10.1016\/j.seizure.2026.07.001_bib0069","article-title":"Cerebrospinal fluid and serum cytokine profiles in severe viral encephalitis with implications for refractory status epilepticus: a retrospective observational study","volume":"16","author":"Huang","year":"2025","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.seizure.2026.07.001_bib0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0028-3843(14)60080-3","article-title":"[Epilepsy and pro-inflammatory cytokines. Immunomodulating properties of antiepileptic drugs]","volume":"45","author":"Andrzejczak","year":"2011","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"10.1016\/j.seizure.2026.07.001_bib0071","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2007.08.012","article-title":"Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy","volume":"29","author":"Ravizza","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1016\/j.seizure.2026.07.001_bib0072","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0034-15.2015","article-title":"Rapid, coordinate inflammatory responses after experimental febrile status epilepticus: implications for epileptogenesis","volume":"2","author":"Patterson","year":"2015","journal-title":"eNeuro"},{"issue":"12","key":"10.1016\/j.seizure.2026.07.001_bib0073","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1523\/JNEUROSCI.19-12-05054.1999","article-title":"Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures","volume":"19","author":"Vezzani","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.seizure.2026.07.001_bib0074","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.969364","article-title":"Time and age dependent regulation of neuroinflammation in a rat model of mesial temporal lobe epilepsy: correlation with human data","volume":"10","author":"Erisken","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"17","key":"10.1016\/j.seizure.2026.07.001_bib0075","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1016\/S0021-9258(18)68502-3","article-title":"The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta","volume":"263","author":"Hazuda","year":"1988","journal-title":"J Biol Chem"},{"issue":"18","key":"10.1016\/j.seizure.2026.07.001_bib0076","first-page":"5751","article-title":"Clearance and tissue distribution of recombinant human interleukin 1 beta in rats","volume":"50","author":"Kudo","year":"1990","journal-title":"Cancer Res"},{"issue":"30","key":"10.1016\/j.seizure.2026.07.001_bib0077","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat4579","article-title":"Neutrophils: new insights and open questions","volume":"3","author":"Ley","year":"2018","journal-title":"Sci Immunol"},{"issue":"4","key":"10.1016\/j.seizure.2026.07.001_bib0078","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/10715760902751902","article-title":"Involvement of ROS in BBB dysfunction","volume":"43","author":"Pun","year":"2009","journal-title":"Free Radic Res"},{"issue":"5","key":"10.1016\/j.seizure.2026.07.001_bib0079","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1203\/01.PDR.0000141523.68664.4A","article-title":"Evaluation of IL-8-concentrations in plasma and lysed EDTA-blood in healthy neonates and those with suspected early onset bacterial infection","volume":"56","author":"Orlikowsky","year":"2004","journal-title":"Pediatr Res"},{"issue":"12","key":"10.1016\/j.seizure.2026.07.001_bib0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","volume":"18","author":"Jones","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.seizure.2026.07.001_bib0081","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3390\/cancers11111704","article-title":"Jak-stat signaling induced by interleukin-6 family cytokines in hepatocellular carcinoma","volume":"11","author":"Lokau","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.seizure.2026.07.001_bib0082","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s13365-017-0554-8","article-title":"The role of peripheral interleukin-6 in the development of acute seizures following virus encephalitis","volume":"23","author":"Cusick","year":"2017","journal-title":"J Neurovirol"},{"issue":"4","key":"10.1016\/j.seizure.2026.07.001_bib0083","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.4049\/jimmunol.171.4.1684","article-title":"Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals","volume":"171","author":"Cassese","year":"2003","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.seizure.2026.07.001_bib0084","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12974-019-1452-1","article-title":"Interleukin-10 inhibits interleukin-1beta production and inflammasome activation of microglia in epileptic seizures","volume":"16","author":"Sun","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"5","key":"10.1016\/j.seizure.2026.07.001_bib0085","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s12264-023-01170-2","article-title":"Interleukins in epilepsy: friend or foe","volume":"40","author":"Dong","year":"2024","journal-title":"Neurosci Bull"},{"issue":"1","key":"10.1016\/j.seizure.2026.07.001_bib0086","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22806-9","article-title":"GABA(A) receptor function is enhanced by Interleukin-10 in human epileptogenic gangliogliomas and its effect is counteracted by Interleukin-1beta","volume":"12","author":"Ruffolo","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.seizure.2026.07.001_bib0087","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fneur.2017.00331","article-title":"Cerebrospinal fluid and microdialysis cytokines in severe traumatic brain injury: a scoping systematic review","volume":"8","author":"Zeiler","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2026.07.001_bib0088","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1742-2094-9-255","article-title":"Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infection","volume":"9","author":"Hopkins","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"11","key":"10.1016\/j.seizure.2026.07.001_bib0089","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1097\/MS9.0000000000001176","article-title":"Factors influencing refusal of lumbar puncture in children under age 10: a cross-sectional study","volume":"85","author":"Masood","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"issue":"2","key":"10.1016\/j.seizure.2026.07.001_bib0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nbd.2008.10.002","article-title":"Antagonism of peripheral inflammation reduces the severity of status epilepticus","volume":"33","author":"Marchi","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"9","key":"10.1016\/j.seizure.2026.07.001_bib0091","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1528-1167.2011.03080.x","article-title":"Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures","volume":"52","author":"Marchi","year":"2011","journal-title":"Epilepsia"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126001925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126001925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:29:15Z","timestamp":1789914555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131126001925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":90,"alternative-id":["S1059131126001925"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2026.07.001","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time-dependent changes in cerebrospinal fluid cytokines in NORSE and FIRES: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2026.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 British Epilepsy Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}